{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:56:09Z","timestamp":1792806969868,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jconrel.2024.02.028","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T11:48:38Z","timestamp":1708775318000},"page":"184-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus"],"prefix":"10.1016","volume":"368","author":[{"given":"T.C.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.Y.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N.","family":"Miyaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229558","article-title":"Pneumococcal colonisation is an asymptomatic event in healthy adults using an experimental human colonisation model","volume":"15","author":"Trimble","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.02.028_bb0010","unstructured":"World Health Organization, Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper, Wkly Epidemiol. Rec. 94.8 (2019) 85\u2013104. https:\/\/www.who.int\/publications\/i\/item\/10665-310968 (accessed 11 Jun 2023)."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0015","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6.7","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2024.02.028_bb0020","first-page":"2221","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400.10369","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jconrel.2024.02.028_bb0025","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/iai.62.6.2582-2589.1994","article-title":"Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization","volume":"62","author":"Weiser","year":"1994","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.028_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00024-23","article-title":"Discovery and characterization of pneumococcal serogroup 36 capsule subtypes, serotypes 36A and 36B","volume":"61","author":"Ganaie","year":"2023","journal-title":"J. Clin. Microbiol."},{"issue":"25","key":"10.1016\/j.jconrel.2024.02.028_bb0035","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.vaccine.2016.04.006","article-title":"Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program","volume":"34","author":"Moreira","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.028_bb0040","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004","volume":"196","author":"Hicks","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"36","key":"10.1016\/j.jconrel.2024.02.028_bb0045","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2019.07.043","article-title":"Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil","volume":"37","author":"Brandileone","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jconrel.2024.02.028_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166736","article-title":"NLM, impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41479-023-00109-5","article-title":"Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis","volume":"15","author":"Hu","year":"2023","journal-title":"Pneumonia"},{"issue":"7","key":"10.1016\/j.jconrel.2024.02.028_bb0060","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.vaccine.2019.12.022","article-title":"Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015\u20132017","volume":"38","author":"Nakano","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jconrel.2024.02.028_bb0065","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/vaccines9111338","article-title":"Pneumococcal vaccines: past findings, present work, and future strategies","volume":"9","author":"Oliveira","year":"2021","journal-title":"Vaccines"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2024.02.028_bb0070","first-page":"S87","article-title":"The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae","volume":"19","author":"Briles","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.028_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/pathogens9040278","article-title":"Efficacy of a protein vaccine and a conjugate vaccine against co-colonization with vaccine-type and non-vaccine type pneumococci in mice","volume":"9","author":"Colichio","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/IAI.72.1.114-122.2004","article-title":"Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface","volume":"72","author":"Ren","year":"2004","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.028_bb0085","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/IAI.67.9.4720-4724.1999","article-title":"Pneumococcal surface protein a inhibits complement activation by Streptococcus pneumoniae","volume":"67","author":"Tu","year":"1999","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.028_bb0090","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.72.9.5031-5040.2004","article-title":"PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]","volume":"72","author":"Shaper","year":"2004","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/jb.174.2.601-609.1992","article-title":"Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis","volume":"174","author":"Yother","year":"1992","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.028_bb0100","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/jb.176.10.2976-2985.1994","article-title":"Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA","volume":"176","author":"Yother","year":"1994","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.028_bb0105","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"Hollingshead","year":"2000","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.jconrel.2024.02.028_bb0110","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JCM.00156-06","article-title":"Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil","volume":"44","author":"Pimenta","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1099\/jmm.0.46268-0","article-title":"Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50\u00a0years of age collected in seven countries","volume":"55","author":"Hollingshead","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.617573","article-title":"Distribution and variation of serotypes and pneumococcal surface protein a clades of Streptococcus pneumoniae strains isolated from adult patients with invasive pneumococcal disease in Japan","volume":"11","author":"Chang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191692","article-title":"Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection","volume":"13","author":"Rodrigues","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jconrel.2024.02.028_bb0130","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/pharmaceutics14061238","article-title":"Pneumococcal surface protein A-hybrid nanoparticles protect mice from lethal challenge after mucosal immunization targeting the lungs","volume":"14","author":"Figueiredo","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11095-012-0891-5","article-title":"Nanocarriers targeting dendritic cells for pulmonary vaccine delivery","volume":"30","author":"Kunda","year":"2013","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijpharm.2015.09.034","article-title":"Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles","volume":"495","author":"Kunda","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2024.02.028_bb0145","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/14760584.7.8.1141","article-title":"Epaxal\u00ae: a virosomal vaccine to prevent hepatitis A infection","volume":"7","author":"Bovier","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2024.02.028_bb0150","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal\u00aeV a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"Mischler","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jconrel.2024.02.028_bb0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant zoster vaccine (Shingrix\u00ae): a review in herpes zoster","volume":"35","author":"Syed","year":"2018","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0925-4439(98)00061-1","article-title":"The role of lipids in pulmonary surfactant","volume":"1408","author":"Veldhuizen","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-291X(91)91366-K","article-title":"A novel cationic liposome reagent for efficient transfection of mammalian cells","volume":"179","author":"Gao","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.028_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139785","article-title":"Intranasal immunization with DOTAP cationic liposomes combined with DC-cholesterol induces potent antigen-specific mucosal and systemic immune responses in mice","volume":"10","author":"Tada","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.02.028_bb0180","series-title":"New Comprehensive Biochemistry","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-7306(02)36016-2","article-title":"Sphingolipids: Metabolism and cell signaling","author":"Merrill","year":"2002"},{"key":"10.1016\/j.jconrel.2024.02.028_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2022.108527","article-title":"iNKT cell agonists as vaccine adjuvants to combat infectious diseases","volume":"513","author":"Li","year":"2022","journal-title":"Carbohydr. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2024.02.028_bb0190","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/glycob\/cwab046","article-title":"Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease","volume":"31","author":"Reza","year":"2021","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.jconrel.2024.02.028_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00251-016-0925-y","article-title":"Glycolipid activators of invariant NKT cells as vaccine adjuvants","volume":"68","author":"Kharkwal","year":"2016","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/imt.13.175","article-title":"Optimizing NKT cell ligands as vaccine adjuvants","volume":"6","author":"Carre\u00f1o","year":"2014","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.jconrel.2024.02.028_bb0205","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00253-016-7983-9","article-title":"Production and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content","volume":"101","author":"Figueiredo","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CVI.00430-09","article-title":"Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection","volume":"17","author":"Moreno","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/mi.2017.43","article-title":"NLM, regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia","volume":"11","author":"Smith","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.028_bb0220","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2015.07.015","article-title":"Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein","volume":"492","author":"Kunda","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6750-2-9","article-title":"Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer","volume":"2","author":"Colletier","year":"2002","journal-title":"BMC Biotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.02.028_bb0235","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11095-012-0720-x","article-title":"Protein encapsulation in Unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction","volume":"29","author":"Xu","year":"2012","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2011.07.012","article-title":"A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment","volume":"419","author":"Xu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110552","article-title":"Encapsulation of an endostatin peptide in liposomes: stability, release, and cytotoxicity study","volume":"185","author":"Rezaei","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17425247.2020.1702643","article-title":"Physical stability of dry powder inhaler formulations","volume":"17","author":"Shetty","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.028_bb0255","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/jps.21825","article-title":"Mechanisms of protein stabilization in the solid state","volume":"98","author":"Chang","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejps.2007.12.007","article-title":"Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?","volume":"33","author":"Hulse","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0265","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijms.2015.09.016","article-title":"Selective quantitation of the incorporation of the immunomodulator \u03b1-galactosylceramide in liposomes using LC\u2013MS\/MS","volume":"392","author":"Kaneko","year":"2015","journal-title":"Int. J. Mass Spectrom."},{"issue":"25","key":"10.1016\/j.jconrel.2024.02.028_bb0270","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.vaccine.2009.01.047","article-title":"Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy","volume":"27","author":"Thapa","year":"2009","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.jconrel.2024.02.028_bb0275","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2009.01.083","article-title":"Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens","volume":"27","author":"Courtney","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.028_bb0280","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41385-019-0159-z","article-title":"Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines","volume":"12","author":"Davitt","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"13","key":"10.1016\/j.jconrel.2024.02.028_bb0285","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","article-title":"An oral B subunit: whole cell vaccine against cholera","volume":"10","author":"Holmgren","year":"1992","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41541-019-0139-z","article-title":"An oral alpha-galactosylceramide adjuvanted helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses","volume":"4","author":"Longet","year":"2019","journal-title":"npj Vaccines"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.028_bb0295","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CVI.00400-07","article-title":"Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)\/IgG2a ratio and proinflammatory cytokine production","volume":"15","author":"Ferreira","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.028_bb0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/acsmedchemlett.5b00340","article-title":"Design, synthesis, and immunological evaluation of Benzyloxyalkyl-substituted 1,2,3-Triazolyl \u03b1-GalCer analogues","volume":"7","author":"Verma","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0305","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.intimp.2018.06.027","article-title":"Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice","volume":"61","author":"Tada","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0310","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.actbio.2019.03.049","article-title":"Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection","volume":"90","author":"Kye","year":"2019","journal-title":"Acta Biomater."},{"issue":"325","key":"10.1016\/j.jconrel.2024.02.028_bb0315","article-title":"Room temperature stable PspA-based nanovaccine induces protective immunity","volume":"9","author":"Wagner-Mu\u00f1iz","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.028_bb0320","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1016\/j.actbio.2013.06.006","article-title":"Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles","volume":"9","author":"Haughney","year":"2013","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.02.028_bb0325","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae","volume":"81","author":"Kong","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0330","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","volume":"8","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.028_bb0335","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.molpharmaceut.0c01003","article-title":"Characterization and specification of a trivalent protein-based pneumococcal vaccine formulation using an adjuvant-free nanogel nasal delivery system","volume":"18","author":"Yuki","year":"2021","journal-title":"Mol. Pharm."},{"issue":"25","key":"10.1016\/j.jconrel.2024.02.028_bb0340","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2021.04.069","article-title":"A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci","volume":"39","author":"Nakahashi-Ouchida","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.028_bb0345","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41385-019-0218-5","article-title":"Generation of protective pneumococcal-specific nasal resident memory CD4+ T cells via parenteral immunization","volume":"13","author":"O\u2019Hara","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2024.02.028_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.mucimm.2023.07.004","article-title":"GL7 ligand expression defines a novel subset of CD4+ TRM cells in lungs recovered from pneumococcus","author":"Lyon De Ana","year":"2023","journal-title":"Mucosal Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:34:44Z","timestamp":1738100084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":70,"alternative-id":["S0168365924001238"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}